← TrialMatch
HomeTrials

Protocol Validation of Dynamometric Measurement of Passive Inter-segmental Stiffness and S

Cerebral palsy (CP) refers to a group of movement and posture disorders responsible for activity limitation due to brain damage that occurs during fetal development or during the first year of a child's life. Given the multitude of treatment options available, the choice of treatment is a key determinant that greatly i

Condition(s)Cerebral Palsy
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryCerebral palsy (CP) refers to a group of movement and posture disorders responsible for activity limitation due to brain damage that occurs during fetal development or during the first year of a child's life. Given the multitude of treatment options available, the choice of treatment is a key determinant that greatly influences the potential for improvement in motor function. This choice is based in particular on a diagnosis resulting from the comparison of a Clinical Gait Analysis (CGA) and a clinical examination, carried out by a practitioner, aimed at evaluating as accurately as possible the deficiencies present in children with CP. During the latter examination, passive inter-segmental stiffness and spasticity, both limiting factors in the mobility of the child with CP, are assessed. H
Who can participateThe inclusion criteria for PC children are : * A clinical diagnosis of CP noted in the medical record * An age between 7 and 18 years old * Levels I to III for the Global Motor Function Classification System (GMFCS) * Ability to cooperate, understand and follow simple instructions * Patient affiliated to the French social security system * Voluntary patient whose parents have given their consent to participate The inclusion criteria for healthy children are : * An age between 7 and 18 years old * Ability to cooperate, understand and follow simple instructions * Patient affiliated to the French social security system * Voluntary patient whose parents have given their consent to participate Exclusion Criteria: * Medical decision for any reason * Child or parent decision for any reason * Inab
Ages7 Years to 18 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorFondation Ellen Poidatz
LocationsSaint-Fargeau-Ponthierry, France
Start date2020-11-02
NCT IDNCT04596852
Official listinghttps://clinicaltrials.gov/study/NCT04596852

🔍 Search all trials →